Literature DB >> 8322488

Improvement of the immunoglobulin subclass response to influenza vaccine in elderly nursing-home residents by the use of high-dose vaccines.

E J Remarque1, W C van Beek, G J Ligthart, R J Borst, L Nagelkerken, A M Palache, M J Sprenger, N Masurel.   

Abstract

To investigate the effects of age and antigen dose (10, 20, 60 micrograms) on the immunoglobulin (sub) class distribution following influenza vaccination, antibody responses in 79 elderly nursing home residents were compared with the responses in 100 young subjects. At a 10 micrograms dose the IgM, IgG3 and IgA1 responses were comparable in both age groups, whereas the IgG, IgG1 and haemagglutination inhibition (HI) responses were twofold lower in the elderly. A 20 micrograms dose increased the IgG, IgG1 and HI levels in the elderly to the levels in the young and the IgA1 to significantly higher levels. A 60 micrograms dose increased antibody levels in the young, but did not further increase the response in the elderly. The 20 micrograms dose might represent a higher level of protection in the elderly.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8322488     DOI: 10.1016/0264-410x(93)90311-k

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  15 in total

1.  A dose-response evaluation of inactivated influenza vaccine given intranasally and intramuscularly to healthy young adults.

Authors:  Robert L Atmar; Wendy A Keitel; Thomas R Cate; Flor M Munoz; Fred Ruben; Robert B Couch
Journal:  Vaccine       Date:  2007-05-22       Impact factor: 3.641

2.  Neuraminidase-specific antibody responses to inactivated influenza virus vaccine in young and elderly adults.

Authors:  D C Powers; E D Kilbourne; B E Johansson
Journal:  Clin Diagn Lab Immunol       Date:  1996-09

Review 3.  Signals that drive T follicular helper cell formation.

Authors:  Louise M C Webb; Michelle A Linterman
Journal:  Immunology       Date:  2017-07-17       Impact factor: 7.397

4.  Functional disability and antibody response to influenza vaccine in elderly patients in a Dutch nursing home.

Authors:  E J Remarque; H J Cools; T J Boere; R J van der Klis; N Masurel; G J Ligthart
Journal:  BMJ       Date:  1996-04-20

5.  Age-related increase in the fraction of CD27-CD4+ T cells and IL-4 production as a feature of CD4+ T cell differentiation in vivo.

Authors:  E W Nijhuis; E J Remarque; B Hinloopen; T Van der Pouw-Kraan; R A Van Lier; G J Ligthart; L Nagelkerken
Journal:  Clin Exp Immunol       Date:  1994-06       Impact factor: 4.330

6.  Antibody and Th1-type cell-mediated immune responses in elderly and young adults immunized with the standard or a high dose influenza vaccine.

Authors:  Wilbur H Chen; Alan S Cross; Robert Edelman; Marcelo B Sztein; William C Blackwelder; Marcela F Pasetti
Journal:  Vaccine       Date:  2011-02-23       Impact factor: 3.641

Review 7.  Immunodeficiency of aging.

Authors:  E A Burns; J S Goodwin
Journal:  Drugs Aging       Date:  1997-11       Impact factor: 4.271

8.  High dose trivalent influenza vaccine compared to standard dose vaccine in patients with rheumatoid arthritis receiving TNF-alpha inhibitor therapy and healthy controls: Results of the DMID 10-0076 randomized clinical trial.

Authors:  Jack T Stapleton; Nancy Wagner; Rebecca Tuetken; Abbie R Bellamy; Heather Hill; Sonnie Kim; Patricia L Winokur
Journal:  Vaccine       Date:  2020-04-12       Impact factor: 3.641

9.  Influenza vaccination in older patients. Immunogenicity, epidemiology and available agents.

Authors:  H Glathe; W Lange
Journal:  Drugs Aging       Date:  1995-05       Impact factor: 3.923

Review 10.  A systematic mapping review of randomized controlled trials (RCTs) in care homes.

Authors:  Adam L Gordon; Phillipa A Logan; Rob G Jones; Calum Forrester-Paton; Jonathan P Mamo; John R F Gladman
Journal:  BMC Geriatr       Date:  2012-06-25       Impact factor: 3.921

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.